Immatics (IMTX) Total Current Liabilities (2019 - 2025)

Immatics (IMTX) reported Total Current Liabilities of $50.1 million for Q4 2025, down 31.08% on a YoY basis from $72.7 million in Q4 2024, and down 31.21% sequentially from $72.8 million in Q3 2025.

Immatics (IMTX) Total Current Liabilities (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Total Current Liabilities data on file, last reported at $50.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 31.08% year-over-year to $50.1 million; the trailing twelve-month figure through Dec 2025 stood at $50.1 million (down 31.08% YoY), and the FY2025 full-year result was $48.6 million, down 33.96% from the prior year.
  • Total Current Liabilities eased to $50.1 million in Q4 2025, from $72.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $168.4 million in Q4 2023 to a low of $50.1 million in Q4 2025.
  • A 5-year average of $111.9 million and a median of $111.0 million in 2021 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities soared 55.09% in 2023 and sank 63.78% in 2025, its largest moves.
  • Tracing IMTX's Total Current Liabilities over 5 years: stood at $108.8 million in 2021, then slipped by 0.22% to $108.6 million in 2022, then soared by 55.09% to $168.4 million in 2023, then sank by 56.87% to $72.7 million in 2024, then plunged by 31.08% to $50.1 million in 2025.
  • Business Quant data shows IMTX's Total Current Liabilities at $50.1 million in Q4 2025, $72.8 million in Q3 2025, and $64.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 56.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 289.60 Mn
10 Immatics 1.11 Bn 1.11 Bn - 50.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 50.07 Mn
Sep 30, 2025 72.78 Mn
Jun 30, 2025 64.80 Mn
Mar 31, 2025 58.66 Mn
Dec 31, 2024 72.65 Mn
Sep 30, 2024 141.57 Mn
Jun 30, 2024 161.04 Mn
Mar 31, 2024 161.98 Mn
Dec 31, 2023 168.44 Mn
Sep 30, 2023 131.88 Mn
Jun 30, 2023 135.36 Mn
Mar 31, 2023 107.96 Mn
Dec 31, 2022 108.61 Mn
Sep 30, 2022 125.15 Mn
Jun 30, 2022 121.64 Mn
Mar 31, 2022 103.09 Mn
Dec 31, 2021 108.85 Mn
Sep 30, 2021 126.33 Mn
Jun 30, 2021 113.12 Mn
Mar 31, 2021 103.84 Mn